What should be the next treatment direction for this breast cancer patient?

Indeed, as stated in the report, the molecular type is HER-2 and the prognosis is relatively poor. It is recommended to use Herceptin**, now Beijing, Shanghai and Guangzhou have free drug programs, buy 6, that is, 150,000, and then cancer** will send 8, if you want to use it, you can go to the hospital in these places for treatment.

In addition, there is a real possibility of breast cancer in the contralateral breast, which is why doctors emphasize postoperative follow-up. It is recommended to do a surgical biopsy, if the pathology is cancer, you can choose breast-conserving surgery or modified ** surgery, you still need to do chemotherapy after surgery, you can use the original regimen, you can also use a new drug, this will be said later. The patient is 42 years old, relatively young, although the hormone receptor is negative and the endocrine ** effect is limited, it is still recommended to undergo ovarian function suppression after surgery, specifically with goserelin (norred) for 28 days for 2 years.

If it is malignant, it is most likely to be the primary cancer of the left breast, which is equivalent to another tumor, and the previous right breast cancer has been **, and the two can be regarded as independent. It is recommended to still have ** surgery. Postoperatively, the specific regimen of chemotherapy, radiotherapy, and endocrine therapy should still be determined according to pathology.

There are many chemotherapy regimens for breast cancer, and the chemotherapy effect is relatively good, so even if you don't need to target**, you can choose other types of second-line and third-line chemotherapy drugs.

If the pathology suggests that it is a benign nodule, it is OK to cut it off, and no further ** is required.

Left breast nodule refers to the left breast nodule, and there is no such thing as a nodule.

Is there any change in the nodules between February and December?

If the doctor recommends a pathological examination and the result is not good, it is considered to be disease progression, contralateral breast metastasis, surgery and postoperative chemotherapy can also be used, and radiotherapy can also be considered if there is no radiotherapy in the past. Immunohistochemistry can also be done for new lesions, and it has been reported in the literature that breast cancer metastases ER, PR, and HER-2 may drift, and endocrine** and molecular targeting** can be considered according to the results.

Now there is a new policy, Herceptin Targeted ** can be given free drugs, but you need to pay for the first 6 cigarettes first, and you can apply for free drugs later, you can learn more from the bed doctor.

I don't think surgery is needed at all, Chinese medicine ** is completely fine.

If breast cancer is in its early stages, I personally recommend being conservative** and more prudent. Because I don't recommend surgery unless it is absolutely necessary, this disease is so special, some people want to live with dignity, and they would rather die than have it removed.

Breast cancer has been confirmed, it should be to remove the breast, the early ** rate is very high, calm down, find a big hospital**, the medical level is high, and the success rate is also high.

Early breast cancer can be obtained, you need to go to a regular hospital, so that the doctor can correctly assess whether the cancer cells have spread to the lymph nodes, and formulate a specific surgical plan, after the operation, it is necessary to cooperate with chemotherapy and radiotherapy to control the cancer cells. Thus restoring the body to health.

Hello, the current breast cancer methods mainly include: surgery, radiation, endocrine, chemical drugs, molecular targeting, traditional Chinese medicine and immunity, etc.

1) Surgery**: It is a first-class method for early-stage breast cancer, and it is often used as a palliative method for more advanced breast cancer. Total mastectomy, coupled with axillary dissection, preserves the pectoral muscles, and is considered to be the contemporary norm for patients and some patients**.

2) Radiation: It is one of the main methods of this disease, and it is a local method. Radiation** Applied to:

**Sexual Radiation**; Preoperative and postoperative adjuvants**; Palliative radiation**. (3) endocrine** (4) chemical drugs**; (5) Biological** and molecularly targeted**(6) Traditional Chinese medicine**: Traditional Chinese medicine (such as ginsenoside RH2) is a beneficial supplement in breast cancer**, which can delay tumor progression by regulating body functions, enhancing one's own anti-cancer ability; Combined with chemotherapy and radiotherapy, it can reduce toxicity and side effects and improve anti-cancer effects.

At present, the enrichment technology of ginsenoside Rh2 has been very mature, and the products with higher ingredients include "Jinxing" capsules, which contain as much as high. (7) Immunity**: For many years, people have been exploring the application of immunology to breast cancer.

Theoretically, immunity is the most specific, only killing tumor cells, no harm to normal tissues, and the effect is systemic and suitable for non-limited tumors. However, due to the complex immune escape mechanism in tumor tissues, the current effect of immunity is not satisfactory.

In general, it is recommended that breast cancer patients do not consider the use of simple Western medicine**, which will cause different degrees of harm, and the best way to use the combination of traditional Chinese and Western medicine is for breast cancer**.

On August 6, Pfizer announced that the world's first cyclin-dependent kinase (CDK)4 6 inhibitor Aiboxin (palbociclib) has been approved by the State Food and Drug Administration on July 31.

According to reports, Aiboxin is suitable for **hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, and should be used in combination with aromatase inhibitors as the initial endocrine of postmenopausal female patients**. The global registration study showed that the median progression-free survival of patients with Letrozole** hormone receptor (HR)-positive and human epidermal growth factor receptor-2 (HER-2)-negative was as long as one month, and compared with letrozole alone, Aiboxin and Letrozole** significantly extended the median progression-free survival of patients with advanced breast cancer by 10 months.

Data show that breast cancer is the number one malignant tumor that seriously threatens women's health worldwide. In 2015, there were 10,000 new cases of breast cancer and more than 70,000 deaths in China. The situation of advanced breast cancer is even more severe, with 1 in 10 new patients diagnosed with advanced breast cancer each year, and 30-40% of patients with early-stage breast cancer who have undergone surgery and standardization** will develop advanced breast cancer.

According to the news, in 2013, the FDA approved Aiboxin as a breakthrough new drug for advanced breast cancer, and in 2015, Aibo was newly listed. Based on this breakthrough, the National Comprehensive Cancer Network guidelines recommend Aiboxin in combination with aromatase inhibitors as HR+

HER2 - first-line regimen for advanced or metastatic breast cancer**. Up to now, Aiboxin has been approved for listing in 86 countries and regions around the world, and China is the 87th.

Breast cancer in general is a lot of means, so at present we are talking about the synthesis of breast cancer, the synthesis of breast cancer includes breast cancer, a surgery, breast cancer radiotherapy, breast cancer chemotherapy, breast cancer targeting, of course, also includes our traditional Chinese medicine, breast cancer surgery**is breast cancer, a very important link, we have a saying, there are conditions to go on without conditions to create conditions, that is, surgery, then breast, Other ** also includes, chemotherapy for breast cancer, chemotherapy for breast cancer, he is a means of the whole body, it uses cytotoxic drugs to directly kill tumor cells, then it is actually unable to distinguish between good cells and bad cells, so while killing tumor cells, it will also have an impact on normal cells, so many patients in the process of chemotherapy, due to the damage to normal cells, there will be vomiting.

Hair loss, low blood cells, and other adverse reactions, then there is another ** is radiotherapy, radiotherapy and breast cancer surgery**, both belong to the local **, then it is the use of radiation in the local area of irradiation to reduce the risk of breast cancer local **, can also bring patients distant survival, etc., some benefits, there is some endocrine **, then not all breast cancer patients, are suitable for endocrine**, only estrogen receptor or progesterone, Receptor-positive patients, acceptable endocrine**, and a target**, then we say that we have now entered an era of precision, so targeting** actually reflects the meaning of this precision**, which is currently relatively mature.

The widely used targeting** is aimed at a target like HER2, so for HER2-positive breast cancer, the application of targeted ** can bring survival benefits to others can be increased by 30% to 40%, it is a milestone leap, so finally, there is our Chinese medicine **, the Chinese medicine is a full participation in the whole process of breast cancer, then it can improve the recovery of breast cancer patients after breast cancer surgery, a perioperative period, It can alleviate the toxicity and side effects of radiotherapy and chemotherapy, so it can improve the patient's survival expectation, so the best method of traditional Chinese medicine is also very important.

The recently launched Aiboxin is aimed at hormone receptor-positive, HER2-negative postmenopausal breast cancer patients;

See another page for questions.

3.How to get rid of neck edema?

You can try:15 grams of barley flour, rinse.

2.Dihydrogram urithine 25mg 1 servings per day.

Concomitant use of spironolactone 20mg once daily.

After taking it for 3-4 days, stop using it for 3-4 days. Take care to monitor blood electrolytes.

4.Other suggestions? "Retinal detachment of the right eye Examination Hospital: Lianyungang Eye Hospital.

Eye ultrasound examination "see ophthalmology."

Erection of the right eye retinal detachment Examination hospital: Lianyungang Eye Hospital.

Eye ultrasound examination "see ophthalmology."

Dr. Liu Xiaofeng of Nanjing Younoisy Maternal and Child Health Hospital solemnly reminded that because the patient cannot be seen face-to-face and cannot fully understand the condition, the above suggestions are for reference only, and the specific diagnosis and treatment must be carried out in the hospital under the guidance of the doctor! ）

Advanced breast cancer refers to cases that have clear distant metastases, at this time, most of the patients are in poor general condition, and their tolerance to a series of ** blows is reduced. Therefore, how to develop a comprehensive program is very important for the success of the program and the prognosis of patients.

1) It is generally believed that chemotherapy + surgery + radiotherapy + endocrine** is a safe plan.

Preoperative chemotherapy or local radiotherapy can shrink the primary tumor or control the metastases to a certain extent, so that the original inoperable cases can be given the opportunity to operate; Postoperative adjuvant chemotherapy and radiotherapy can reduce the chance of postoperative metastasis or radiotherapy and improve the survival rate.

Early oophorectomy is necessary in premenopausal patients with advanced breast cancer who have a positive estrogen receptor test.

2) Traditional Chinese medicine can often alleviate symptoms, alleviate the toxic and side effects caused by the above various diseases, enhance the effect of radiotherapy and chemotherapy, prolong the life of patients, and improve the quality of life, so it is also worth advocating.

3) Symptomatic is also one of the important means of advanced breast cancer. If patients with advanced breast cancer may have local ulcers and severe pain, appropriate local external treatment and pain relief should be given**; In the case of distant organ metastasis, it should be performed according to the symptoms of the transferred organ involvement**; It should be supported when cachexia is present at a later stage**.

4) In the case of advanced breast cancer patients, psychological care should also be paid enough attention. Encouraging patients to face their diseases correctly, build confidence and courage to overcome tumors, and always cooperate with various ** with a positive mental state is an important aspect of advanced cancer.